Clinical Trial Update: Concurrently vs Sequentially Combined HAIC With Targeted and Immunotherapy in Potentially Resectable HCC [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial registry entry examining concurrent versus sequential hepatic arterial infusion chemotherapy combined with targeted therapy and immunot…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Sun Yat-sen University | Conditions: Hepatocellular Carcinoma, Chemotherapy Effect | Phase 3 | Status: RECRUITING